Conversion of Enkephalin and Dermorphin into Delta-selective Opioid Antagonists by Single-residue Substitution
Overview
Authors
Affiliations
The properties of di- and tri-peptides containing 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) in second position suggest that the message domain of opioid peptides can be composed of only two residues [Temussi, P. A., Salvadori, S., Amodeo, P., Guerrini, R., Tomatis, R., Lazarus, L. H., Picone, D. & Tancredi, T. (1994) Biochem. Biophys. Res. Commun. 198, 933-939]. As a crucial test of the possibility that the Tyr-Tic segment be a message domain in longer peptide sequences, we have inserted it in the sequences of two typical opioid peptides: [Leu]enkephalin, a non-selective agonist, and dermorphin, a selective mu agonist. Here we report the synthesis and biological activity of [L-Tic2]enkephalin, [L-Tic2]dermorphin, [L-Tic2]dermorphin carboxylic acid and [D-Tic2]dermorphin: all [L-Tic2]peptides were converted from agonists to delta-selective antagonists. The NMR conformational study in a dimethylsulfoxide/water cryoprotective mixture at low temperature shows diagnostic side-chain--side-chain NOEs in the spectra of all [L-Tic2]peptides and hints that the 90 degrees arrangement of the the two aromatic rings found in the cis-Tyr-L-Tic moiety, typical of N-methyl naltrindole and other delta-selective opiate antagonists, is responsible for the antagonist activity of all these peptides.
Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.
Lee Y Biomolecules. 2022; 12(9).
PMID: 36139079 PMC: 9496382. DOI: 10.3390/biom12091241.
Lee Y, Qu H, Davis P, Ma S, Vardanyan R, Lai J ACS Med Chem Lett. 2014; 4(7):656-659.
PMID: 24648867 PMC: 3956057. DOI: 10.1021/ml400115n.
Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold.
Ballet S, Feytens D, De Wachter R, De Vlaeminck M, Marczak E, Salvadori S Bioorg Med Chem Lett. 2008; 19(2):433-7.
PMID: 19062273 PMC: 2742322. DOI: 10.1016/j.bmcl.2008.11.051.
Salvadori S, Attila M, Balboni G, Bianchi C, Bryant S, Crescenzi O Mol Med. 1995; 1(6):678-89.
PMID: 8529134 PMC: 2229973.